Tolterodine Tartrate

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 70436-161
  • Package NDC 70436-161-02
  • Package NDC 70436-161-04
  • Package NDC 70436-161-06
  • Application number ANDA213858
  • SPL ID 5849c8cc-3ff6-8feb-e063-6394a90a2953
  • SPL set ID bbbee85a-e5e2-24ec-e053-2995a90acfd8
  • UNII 5T619TQR3R
  • RxCUI 855182
  • RxCUI 855189

What the source publishes

Labeler
Slate Run Pharmaceuticals, LLC
Active ingredients
Tolterodine Tartrate
Form
CAPSULE, EXTENDED RELEASE
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:70436-161_5849c8cc-3ff6-8feb-e063-6394a90a2953
{
  "name": "Tolterodine Tartrate",
  "splId": "5849c8cc-3ff6-8feb-e063-6394a90a2953",
  "labels": [
    {
      "setId": "bbbee85a-e5e2-24ec-e053-2995a90acfd8",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bbbee85a-e5e2-24ec-e053-2995a90acfd8",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bbbee85a-e5e2-24ec-e053-2995a90acfd8"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Slate Run Pharmaceuticals, LLC",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70436-161-02)",
      "package_ndc": "70436-161-02",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20210412"
    },
    {
      "sample": false,
      "description": "30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70436-161-04)",
      "package_ndc": "70436-161-04",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20210412"
    },
    {
      "sample": false,
      "description": "90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70436-161-06)",
      "package_ndc": "70436-161-06",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20210412"
    }
  ],
  "productId": "70436-161_5849c8cc-3ff6-8feb-e063-6394a90a2953",
  "useDomain": "unknown",
  "dosageForm": "CAPSULE, EXTENDED RELEASE",
  "productNdc": "70436-161",
  "deaSchedule": null,
  "genericName": "Tolterodine Tartrate",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "TOLTERODINE TARTRATE",
      "strength": "4 mg/1"
    }
  ],
  "applicationNumber": "ANDA213858",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20210412",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "upc": [
      "0370436160020",
      "0370436160068",
      "0370436161041",
      "0370436160044",
      "0370436161027",
      "0370436161065"
    ],
    "unii": [
      "5T619TQR3R"
    ],
    "rxcui": [
      "855182",
      "855189"
    ],
    "spl_set_id": [
      "bbbee85a-e5e2-24ec-e053-2995a90acfd8"
    ],
    "manufacturer_name": [
      "Slate Run Pharmaceuticals, LLC"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:70436-161_5849c8cc-3ff6-8feb-e063-6394a90a2953"